HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 24, No. 07, July 2020 – Mitigating the Impact of COVID-19: How is Food Security Threatened?       » COVID-19 vaccine Reaches Phase I Clinical Trial       » Mathematical Model to Define Eruptive Stages of Young Volcanic Rocks       » Artificial Intelligence to Tackle Agricultural Challenges       » Installation of Mobile X-Ray System at COVID-19 Screening Center in Korea       » World's First Spherical Artificial Eye      
Click here to download ISSUE PDF
Vol 16, No 12, December 2012 - Best of APBN 2012
Contents

EDITORIAL

BioBoard

Indonesia
•  Quintiles expands patient access for clinical trials to Indonesia

Japan
•  Legacy Healthcare announces breakthrough clinical results in hair re-growth

Singapore
•  iNova Pharmaceuticals relocates regional HQ to Singapore as part of Asia-centric reorganization

Australia
•  Silencing the bird flu gene: scientists prep live hen trials
•  Helsinn grants Specialised Therapeutics Australia (STA) rights to Anamorelin, to treat cachexia-anorexia

North America
•  To survive, genes pick up new skills
•  Phase III study evaluates two investigational hormone-releasing IUDs for prevention of pregnancy for up to three years
•  Agilent Technologies introduces SureDesign
•  Progress made towards production of biosimilar products in tobacco plants
•  FDA approves Aerospan for asthma

Europe
•  New technology offers improved chances for couples undergoing IVF
•  Phase IIa Laquinimod trial results show positive data for potential use in active Crohn’s Disease
•  Pfizer donates vials of Factor IX to the World Federation of Hemophilia
•  nViso gets research grant to study 3D facial imaging technology for healthcare applications
•  New evidence-based 3D cell culture web portal launched by Reinnervate Ltd
•  The social side of vaccine effectiveness

Eye on China
•  BG Medicine announces agreement with Kindstar Diagnostics which will provide Galectin-3 testing services in China
•  MicuRx lands $9.6 Million to fund China trials of antibiotic
•  AstraZeneca and Ironwood announce linaclotide collaboration for China
•  BGI-Shenzhen extends tender offer for Complete Genomics, Inc.
•  China Cord Blood Corporation continues share repurchase program
•  NCKU, Science Park join hands to boost academia-industry collaboration
•  Pharmaron forms strategic partnership with AstraZeneca to accelerate drug discovery
•  Regulatory mechanisms of an acid-activated type VI secretion system in Agrobacterium tumefaciens
•  Seasonal plasticity of peripheral auditory sensitivity associated with vocal communication in frog

Features
•  Metabolic Syndrome and Diabetes: Current Asian Perspectives
•  A Crisis in the Development of Antibiotics
•  The Marketing of Unapproved Stem Cell Products: An Industry-wide Challenge
•  Draining the Goodwill of Science – The Direct-to-Consumer Genetic Testing Industry in East Asia
•  Biodiesel – From Lab to Industry
•  The Appearance and Development of Commercial Laboratories in China
•  Cord Blood Banking – To Go Public or Stay Private
•  Open Source – The Future of Drug Discovery
•  Vaccines – Where are we headed?
•  Leveraging on External Expertise

Inside Industry
•  InDex Pharmaceuticals granted Japanese patent for novel treatment of steroid-resistant inflammation
•  RCC announces marketing partnership with ViruSure for India
•  InteRNA Technologies receives notice of allowance for miRNA sequences of its lead pre-clinical product
•  Mederi Therapeutics signs exclusive agreement with Farouq, Maamoun, Tamer & Co. to distribute the new Stretta(R) and Secca(R) Systems in the Kingdom of Saudi Arabia
•  BAC and GE Healthcare collaboration wins industry award

•  Conference Calendar

NEWS CRUNCH  
news Proteona Honoured with "one to watch" Prize in the Inaugural Spinoff Prize by Nature Research and Merck Group
news Twist Bioscience and Proteona Join Hands to Protect Immunocompromised Patients from COVID-19 Infection
news Innovation in Healthcare: IOT-Enabled Tele-Ventilators to Fight Against the COVID-19 Pandemic
news Proteona leads international consortium to develop SARS-CoV-2 neutralizing antibody to help vulnerable immunocompromised individuals
SPOTLIGHT  

MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Contribute to APBN
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2020 World Scientific Publishing Co Pte Ltd  •  Privacy Policy